Diatom-derived mesoporous silica nanoparticles loaded with fucoidan for enhanced chemo-photodynamic therapy. 2023

Min-Hsuan Tsou, and Zhi-Yuan Wu, and Guan-Wei Chen, and Cheng-Chang Lee, and Zui-Harng Lee, and Wei Ting Yuan, and Showe-Mei Lin, and Hsiu-Mei Lin
Department of Bioscience and Biotechnology, National Taiwan Ocean University, Keelung 202, Taiwan.

Combination therapy merges chemical photodynamic therapy (CPDT) to improve cancer treatment. It synergizes chemotherapy with photodynamic therapy (PDT), using photosensitizers to produce reactive oxygen species (ROS) when exposed to light, effectively killing drug-resistant cancer cells. It is not affected by drug resistance, making it an attractive option for combination with chemotherapy. In this study, the focus was on the design of a combination therapy of chemotherapy and PDT. They synthesized diatomaceous earth mesoporous silica nanoparticles (dMSN) containing lanthanide metal ions in a PDT composition. These nanoparticles can generate ROS under near-infrared light irradiation and have MRI and fluorescence imaging capabilities, confirming their phototherapeutic effect on HCT116 cancer cells at a 200 μg/mL concentration. Fucoidan, derived from brown algae, was used as the chemotherapy component. The fucoidan extracted from Sargassum oligocystum in Pingtung Haikou showed the highest anticancer activity, with cell viability of 57.4 % at 200 μg/mL on HCT116 cancer cells. For combination therapy, fucoidan was loaded into nanoparticles (dMSN-EuGd@fucoidan). Cell viability experiments revealed that at 200 μg/mL, the cell survival rate of dMSN-EuGd@Fucoidan on HCT116 cancer cells was 47.7 %. Combination therapy demonstrated superior anticancer efficacy compared to PDT or chemotherapy alone, successfully synthesizing nanoparticles for combined chemotherapy and photodynamic therapy.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D010778 Photochemotherapy Therapy using oral or topical photosensitizing agents with subsequent exposure to light. Blue Light Photodynamic Therapy,Photodynamic Therapy,Red Light PDT,Red Light Photodynamic Therapy,Therapy, Photodynamic,Light PDT, Red,PDT, Red Light,Photochemotherapies,Photodynamic Therapies,Therapies, Photodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012822 Silicon Dioxide Transparent, tasteless crystals found in nature as agate, amethyst, chalcedony, cristobalite, flint, sand, QUARTZ, and tridymite. The compound is insoluble in water or acids except hydrofluoric acid. Silica,Aerosil,Aerosil 380,Cristobalite,Quso G-32,Quso G32,Tridymite,380, Aerosil,Dioxide, Silicon,G32, Quso,Quso G 32
D017319 Photosensitizing Agents Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms. Photosensitizer,Photosensitizers,Photosensitizing Agent,Photosensitizing Effect,Photosensitizing Effects,Agent, Photosensitizing,Agents, Photosensitizing,Effect, Photosensitizing,Effects, Photosensitizing
D017377 Diatoms The common name for the phylum of microscopic unicellular STRAMENOPILES. Most are aquatic, being found in fresh, brackish, and salt water. Diatoms are noted for the symmetry and sculpturing of their siliceous cell walls. They account for 40% of PHYTOPLANKTON, but not all diatoms are planktonic. Bacillariophyta,Bacillariophytas,Diatom
D017382 Reactive Oxygen Species Molecules or ions formed by the incomplete one-electron reduction of oxygen. These reactive oxygen intermediates include SINGLET OXYGEN; SUPEROXIDES; PEROXIDES; HYDROXYL RADICAL; and HYPOCHLOROUS ACID. They contribute to the microbicidal activity of PHAGOCYTES, regulation of SIGNAL TRANSDUCTION and GENE EXPRESSION, and the oxidative damage to NUCLEIC ACIDS; PROTEINS; and LIPIDS. Active Oxygen Species,Oxygen Radical,Oxygen Radicals,Pro-Oxidant,Reactive Oxygen Intermediates,Active Oxygen,Oxygen Species, Reactive,Pro-Oxidants,Oxygen, Active,Pro Oxidant,Pro Oxidants,Radical, Oxygen
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D053758 Nanoparticles Nanometer-sized particles that are nanoscale in three dimensions. They include nanocrystaline materials; NANOCAPSULES; METAL NANOPARTICLES; DENDRIMERS, and QUANTUM DOTS. The uses of nanoparticles include DRUG DELIVERY SYSTEMS and cancer targeting and imaging. Nanocrystalline Materials,Nanocrystals,Material, Nanocrystalline,Materials, Nanocrystalline,Nanocrystal,Nanocrystalline Material,Nanoparticle

Related Publications

Min-Hsuan Tsou, and Zhi-Yuan Wu, and Guan-Wei Chen, and Cheng-Chang Lee, and Zui-Harng Lee, and Wei Ting Yuan, and Showe-Mei Lin, and Hsiu-Mei Lin
January 2018, Colloids and surfaces. B, Biointerfaces,
Min-Hsuan Tsou, and Zhi-Yuan Wu, and Guan-Wei Chen, and Cheng-Chang Lee, and Zui-Harng Lee, and Wei Ting Yuan, and Showe-Mei Lin, and Hsiu-Mei Lin
June 2020, RSC advances,
Min-Hsuan Tsou, and Zhi-Yuan Wu, and Guan-Wei Chen, and Cheng-Chang Lee, and Zui-Harng Lee, and Wei Ting Yuan, and Showe-Mei Lin, and Hsiu-Mei Lin
January 2023, Photochemistry and photobiology,
Min-Hsuan Tsou, and Zhi-Yuan Wu, and Guan-Wei Chen, and Cheng-Chang Lee, and Zui-Harng Lee, and Wei Ting Yuan, and Showe-Mei Lin, and Hsiu-Mei Lin
September 2011, Chemistry, an Asian journal,
Min-Hsuan Tsou, and Zhi-Yuan Wu, and Guan-Wei Chen, and Cheng-Chang Lee, and Zui-Harng Lee, and Wei Ting Yuan, and Showe-Mei Lin, and Hsiu-Mei Lin
April 2024, Pharmaceutics,
Min-Hsuan Tsou, and Zhi-Yuan Wu, and Guan-Wei Chen, and Cheng-Chang Lee, and Zui-Harng Lee, and Wei Ting Yuan, and Showe-Mei Lin, and Hsiu-Mei Lin
December 2010, International journal of pharmaceutics,
Min-Hsuan Tsou, and Zhi-Yuan Wu, and Guan-Wei Chen, and Cheng-Chang Lee, and Zui-Harng Lee, and Wei Ting Yuan, and Showe-Mei Lin, and Hsiu-Mei Lin
March 2009, Chemical communications (Cambridge, England),
Min-Hsuan Tsou, and Zhi-Yuan Wu, and Guan-Wei Chen, and Cheng-Chang Lee, and Zui-Harng Lee, and Wei Ting Yuan, and Showe-Mei Lin, and Hsiu-Mei Lin
January 2024, Lasers in medical science,
Min-Hsuan Tsou, and Zhi-Yuan Wu, and Guan-Wei Chen, and Cheng-Chang Lee, and Zui-Harng Lee, and Wei Ting Yuan, and Showe-Mei Lin, and Hsiu-Mei Lin
December 2015, Nanomaterials (Basel, Switzerland),
Min-Hsuan Tsou, and Zhi-Yuan Wu, and Guan-Wei Chen, and Cheng-Chang Lee, and Zui-Harng Lee, and Wei Ting Yuan, and Showe-Mei Lin, and Hsiu-Mei Lin
October 2016, ACS applied materials & interfaces,
Copied contents to your clipboard!